Page 3 - Bio Call News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Provention Bio Reports First Quarter 2021 Financial Results and Provides Business Update News provided by Share this article Share this article RED BANK, N.J., May 6, 2021 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today reported financial results and provided a business update for the first quarter ended March 31, 2021. "The first quarter of 2021 marked another quarter of strong execution across Provention Bio as we continue to advance our portfolio of autoimmunology therapeutic candidate...

Provention Bio to Report First Quarter 2021 Financial Results on May 6, 2021 News provided by Share this article Share this article RED BANK, N.J., April 29, 2021 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that it will report its first quarter 2021 financial results on Thursday, May 6, 2021, before the opening of the U.S. financial markets. Subsequently, at 8:00 am E.T., the company will host a conference call to discuss its financial results and provide a corporate update....

Provention Bio to Report Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021 - Company also Announces Presentation at the 2021 SVB Leerink Global Healthcare Conference - News provided by Share this article Share this article RED BANK, N.J., Feb. 18, 2021 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that it will report its fourth quarter and full year 2020 financial results on February 25, 2021 before the opening of the U.S. financial markets.  Subsequent...